Literature DB >> 12554885

The new front line treatment for malignant pleural mesothelioma?

J P C Steele.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12554885      PMCID： PMC1746576          DOI： 10.1136/thorax.58.2.96

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  4 in total

1.  BTS randomised feasibility study of active symptom control with or without chemotherapy in malignant pleural mesothelioma: ISRCTN 54469112.

Authors:  M F Muers; R M Rudd; M E R O'Brien; W Qian; A Hodson; M K B Parmar; D J Girling
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

Review 2.  Management options for malignant pleural mesothelioma: clinical and cost considerations.

Authors:  Ranjit K Goudar
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 3.  New therapeutic options for mesothelioma.

Authors:  Ranjit Kumar Goudar
Journal:  Curr Oncol Rep       Date:  2005-07       Impact factor: 5.945

4.  Review of pemetrexed in combination with cisplatin for the treatment of malignant pleural mesothelioma.

Authors:  Ranjit K Goudar
Journal:  Ther Clin Risk Manag       Date:  2008-02       Impact factor: 2.423
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.